Lv71
5000 积分 2023-04-23 加入
P2.06.44 More Than a Mutation: Prevalence of HER2 Overexpression, Amplification, and Mutations by Histology in NSCLC
2天前
已关闭
LGR5 is a biomarker for stratification of HER-2 positive breast cancer patients and personalized treatment
3天前
已完结
Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?
12天前
已完结
Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma
28天前
已完结
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial
28天前
已完结
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
28天前
已完结
Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
1个月前
已完结
Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex
1个月前
已完结
Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1
2个月前
已完结
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
